Few ailments are as fearsome as Alzheimer’s disease, the most common form of dementia, which robs patients of their minds and memories before it takes their lives. So, when the U.S. Food and Drug Administration approved a new treatment for Alzheimer’s in July, the event made front-page news. But it also generated heated arguments.